Active substance
Potassium phosphate
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| POTASSIUM PHOSPHATE 45mM-15ML ADDITIVE | 3 mmol/ml | Injection · Intravenous use | 1 Vial | SAR 9.15 | NCE · Prescription | HOSPIRA INC | Withdrawn by MAH · Not Marketed |
| POTASSIUM PHOSPHATE FTV 15mM-5MLADDITIVE | 3 mmol/ml | Injection · Intravenous use | 1 Vial | SAR 5.80 | NCE · Prescription | HOSPIRA INC | Withdrawn by MAH · Not Marketed |
| POTASSIUM PHOSPHATE INJ 20MINIPLASCO AMP | 3 mmol/ml | Injection · Intravenous use | 1 Bottle | SAR 2.30 | Generic · Prescription | B. BRAUN | Withdrawn by MAH · Not Marketed |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.